Does TRIPTORELIN Cause Prostatic specific antigen increased? 81 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Prostatic specific antigen increased have been filed in association with TRIPTORELIN (TRIPTODUR). This represents 1.5% of all adverse event reports for TRIPTORELIN.
81
Reports of Prostatic specific antigen increased with TRIPTORELIN
1.5%
of all TRIPTORELIN reports
15
Deaths
5
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From TRIPTORELIN?
Of the 81 reports, 15 (18.5%) resulted in death, 5 (6.2%) required hospitalization, and 2 (2.5%) were considered life-threatening.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIPTORELIN. However, 81 reports have been filed with the FAERS database.
What Other Side Effects Does TRIPTORELIN Cause?
Off label use (545)
Death (362)
Ovarian hyperstimulation syndrome (356)
Needle issue (242)
Disease progression (203)
Product dose omission issue (178)
Drug ineffective (175)
Weight increased (167)
Hot flush (153)
Headache (145)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
LEUPROLIDE (2,432)
ABIRATERONE (1,581)
RADIUM RA-223 DICHLORIDE (449)
RELUGOLIX (335)
BICALUTAMIDE (322)
DOCETAXEL (282)
APALUTAMIDE (251)
DENOSUMAB (220)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)
Which TRIPTORELIN Alternatives Have Lower Prostatic specific antigen increased Risk?
TRIPTORELIN vs TRISODIUM
TRIPTORELIN vs TROFINETIDE
TRIPTORELIN vs TROFOSFAMIDE
TRIPTORELIN vs TROPATEPINE
TRIPTORELIN vs TROPICAMIDE